PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
Clinical trial NCT03079011 · COMPLETED
Trial details
- NCT number
- NCT03079011
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-22
- Primary completion
- 2021-04-30
- Enrollment
- 1017
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.